Nephrologist Dr. Jochen Reiser has been named chairman of the Department of Internal Medicine at Rush University Medical Center. Reiser, who joined Rush on Sept. 1, will also serve as the Ralph C. Brown MD professor of internal medicine at Rush University.
“Dr. Reiser is a world-renowned research leader in the field of proteinuric kidney disease. He is credited with finding a major cause of a significant form of chronic kidney disease called focal segmental glomerulosclerosis,” said Dr. Thomas Deutsch, dean of Rush Medical College, provost of Rush University. “He will be a major asset to Rush and we are fortunate to have his leadership in the department of internal medicine.”
Reiser comes to Rush from the University of Miami Leonard M. Miller School of Medicine where he was the Peggy and Harold Katz Family professor of medicine, anatomy and cell biology. He was also the vice chairman for research in the department of medicine, chief of the division of nephrology and hypertension and the founding director of the Peggy and Harold Katz family drug discovery institute. Prior to joining Rush, he also served as interim chairman of medicine for Miami.
Reiser had led a team of international researchers and scientists in discovering the first circulating factor known to start the process leading to focal segmental glomerulosclerosis. They found that a soluble form of the urokinase plasminogen activator receptor (suPAR) is a circulating blood factor that can trigger glomerular kidney disease. Because of Reiser’s discovery, the disease is better understood and researchers can now work towards developing targeted treatments to prevent what suPAR does to the kidney.
Reiser is the author of more than 70 medical and scientific articles. He holds 10 patents and also serves on the editorial board of a number of leading medical journals. Reiser has led international research in molecular mechanisms of glomerular kidney disease. Currently, Reiser has three NIH-funded grants in renal disease and biomedical research. He is a member of the American Society for Clinical Investigation (ASCI) and was most recently also elected to the American Clinical and Climatological Society (ACCA).
Reiser earned his medical degree and PhD (summa cum laude) at the Ruprecht Karls University of Heidelberg, Germany, and served his residency in internal medicine at the Albert Einstein College of Medicine in New York. He completed his fellowship in nephrology at Massachusetts General Hospital and Brigham and Women’s Hospital at Harvard Medical School in Boston. Before going to Miami, Reiser was an assistant professor at Harvard Medical School and the founding director of the program in glomerular disease at the Massachusetts General Hospital.
The Department of Internal Medicine at Rush includes 250 faculty and 14 sections including endocrinology, pulmonary and critical care medicine, rheumatology, hematology and oncology, digestive diseases, geriatrics and palliative care, nephrology, epidemiology, cardiology, hepatology, infectious diseases and general internal medicine.
Read the entire news release.
For more news and information, go to the Rush Newsroom.